Digital Health startup ecosystem
We track 56 organisations in this sector across 6+ countries.
Showing 1–20 of 56 Digital Health
Countries in this sector
Sectors alongside this one
Digital Health results
-
33East
33East was founded by Demetrios Zoppos and Yiannis Eftychiou and selected by the European Investment Fund in 2023 as Cyprus's first EIF-backed venture capital fund. It closed a €26 million debut fund in January 2025, anchored by the Cyprus Equity Fund (NRRP) and private investors including the Bank of Cyprus. The fund targets pre-seed and seed-stage startups with a Cyprus connection, writing cheques of €100K–€1M across enterprise software, fintech, gaming, marketplaces, logistics, digital health, and climate tech. First portfolio companies include Electryone AI, an AI-powered renewable-energy management platform.
-
4YFN Barcelona 2026
Global startup platform co-located with MWC at Fira Gran Via, featuring broad investor and corporate access. Includes the 4YFN Awards 2026 live pitch sequence: top startups pitch on March 2, 2026 with finalists advancing to the March 4, 2026 final during MWC week.
-
6th Digital Health Conference 2026
A focused digital-health conference bringing pharma leaders, DTx specialists, regulators, and investors together around AI, real-world data, and patient-centric innovation. For digital-health founders it offers targeted access to pharma partners and regulatory expertise.
-
Aerska
Aerska is a Dublin-based RNA medicines biotech company that uses proprietary brain shuttle technology to overcome the blood-brain barrier and deliver RNAi therapies for neurological diseases such as Alzheimer's and Parkinson's. Founded in 2025 by Jack O'Meara, Dave Hardwicke, and Stu Milstein, the company emerged from stealth in October 2025 with a $21 million seed round, then closed a $39 million Series A in February 2026 led by EQT Dementia Fund and age1, bringing total funding to $60 million.
-
Agesync
Agesync (Agesync GmbH), established in 2024 and based in Berlin (with a presence in New York), is a physician-led longevity platform that combines at-home blood diagnostics measuring 40-60+ biomarkers with a network of licensed EU doctors who review results and prescribe personalized hormonal therapy, nutrition, training, and supplement protocols. Its dashboard tracks biomarker trends, protocol adherence, and wearable data such as HRV and sleep over quarterly retesting cycles, and its labs are ISO 15189-certified partners in the EU and US.
-
Alex Kaluzny
Alex Kaluzny serves as Chief Technology Officer at Doctolib, one of Europe's foremost digital health unicorns, where he leads engineering and technical architecture for a platform used by over 80 million patients across France, Germany, and Italy. In this role he drives the company's technology strategy including its expansion into AI-assisted clinical tools and cross-border healthcare services. He is a prominent figure in the European health technology ecosystem and a recognised speaker on digital health innovation and enterprise technology at European policy forums.
-
Apex Ventures
Apex Ventures is a Vienna-based seed-stage venture capital firm launched in 2017 by Andreas Schwarzenbrunner, Wolfgang Berner, and Ulrich Gall, focused on deep tech, AI, medical devices, and digital health. The firm manages over EUR 50M and invests EUR 250K-1.5M in science-driven teams with defensible intellectual property, often emerging from leading European research institutions. Apex has backed companies including Prewave, Ribbonfish, and contextflow, and provides hands-on support in technology commercialization and clinical market access.
-
BrightCap Ventures
Founded in 2018 by Georgi Mitov and Elina Halatcheva (joined by Managing Partner Diana Stefanova), BrightCap is a pre-seed and seed VC based in Sofia. Its second fund (BrightCap II) closed at approximately €47.5M in 2025, with the European Investment Fund as a cornerstone LP, and is notable as the first vehicle to blend Recovery and Resilience Facility capital from both Bulgaria and Romania in a single cross-border fund. Managing partners bring operating backgrounds from exits at VMware (Aviaso) and Honeywell (Sciant) rather than traditional finance. BrightCap invests €400K–€3M tickets with sector focus on future of work, digital health, and fintech; the portfolio includes Software Group, Pliant, and FITE.
-
Cathay Innovation
Cathay Innovation is a Paris-headquartered global multi-stage venture capital firm founded in 2015, affiliated with Cathay Capital, with offices in San Francisco, Berlin, Madrid, Shanghai, and Singapore. The firm closed its third fund at $1 billion in 2025 — the largest AI-dedicated fund out of the European Union — bringing total assets under management to over €2.5 billion. Cathay invests in vertical AI, digital health, fintech, mobility, and energy across Europe, North America, and Asia, connecting startups with a corporate network of 20+ Fortune 500 partners. The portfolio of over 120 companies includes Glovo, Ledger, Owkin, Alma, and Descartes Underwriting, with eight unicorns, six IPOs, and 18 acquisitions.
-
Creathor Ventures
Creathor Ventures is a pan-European venture capital firm founded over 30 years ago, managing more than €230 million across funds with offices in Bad Homburg and Zurich. The team has financed over 200 companies as lead or co-lead investors, with more than 20 portfolio companies reaching international stock exchanges. It focuses on deep tech and digital health, investing in areas such as AI, IoT, precision medicine, medtech, and cloud technology, primarily in Germany and Switzerland.
-
Crowberry Capital
Crowberry Capital is a Nordic seed and early-stage venture fund founded in 2017 in Reykjavik, with additional offices in Copenhagen and Stockholm. The all-female founding team backs technology startups across the Nordics, with a particular focus on SaaS, digital health, fintech, and gaming. Its second fund closed at €90 million and the firm has invested in over 34 companies. Notable portfolio companies include Lucinity (AI anti-money laundering) and Mainframe Industries (cloud-native MMO gaming).
-
Dawn Health
Dawn Health develops regulated software-as-a-medical-device products with pharmaceutical and life-science partners. The company builds digital therapeutics and companion applications for adherence, remote monitoring, and real-world clinical data capture in regulated settings.
-
DMEA
Organizer of DMEA, Europe's leading digital health and healthcare IT trade fair held annually in Berlin. Drawing over 16,000 attendees and 700 exhibitors, DMEA showcases innovations in electronic health records, telemedicine, AI diagnostics, and hospital IT infrastructure, serving as a key meeting point for healthtech startups and health system leaders.
-
DMEA 2026
Europe's largest digital health trade fair at Messe Berlin, spanning healthcare IT, procurement, interoperability, and compliant medical software rollout. Includes the 'DMEA fuer Health Startups' program, the DMEA nova Award startup finals, and DMEA Sparks pitch visibility for early-stage health-tech companies.
-
DMEA 2027
DMEA, Europe's leading digital health event, moves to Messe Munich for 2027, running 13-15 April, after previously being held in Berlin. The 2027 programme focuses on AI in healthcare, data and digital sovereignty, cross-sector care and patient-centred health IT. The move to Munich has secured backing from leading industry partners.
-
Estonian HealthTech Week 2026
A week-long showcase of Estonia's e-health, healthtech, and biotech ecosystem, opening in Tallinn and moving to Tartu, and including the DTx New Nordics Conference. Free to attend, designed for healthtech entrepreneurs, startups, clinicians, and investors.
-
Expon Capital
Expon Capital is a Luxembourg-based venture capital firm founded in 2015 by Alain Rodermann, Jérôme Wittamer, Lily Wang, and Marc Gendebien. The firm has deployed over €90 million across 33 companies in 14 countries through successive Digital Tech Funds, with Fund IV planned for 2026. It backs seed and early-stage tech startups across cybersecurity, fintech, regtech, digital health, and edtech, with a particular focus on Luxembourg-origin companies. Notable portfolio successes include Salonkee, which grew to 250+ employees and raised a €28 million Series B led by PeakSpan Capital after Expon's initial investment.
-
FIRE1
FIRE1 is a Dublin-based medtech company developing the NORM heart failure management system, a remote monitoring implant designed to enable patients to control their fluid volume at home, similar to how continuous glucose monitors transformed diabetes care. The device received FDA Breakthrough Device Designation and has been successfully implanted in the first Irish patient at University Hospital Galway. FIRE1 has raised $210 million in total funding, including a $120 million round led by Polaris Partners and Elevage Medical Technologies.
-
Future Health Summit 2026
A two-day summit at the Dublin Royal Convention Centre joining clinicians, hospital managers, pharma, health-tech firms, and policy people. Relevant for digital-health and medtech founders seeking healthcare buyers and partners.
-
Geneva Health Forum 2026
A biennial gathering at Campus Biotech, one of the largest global health conferences, bringing political, private, academic, and civil-society actors together on global health innovation and policy. For a healthtech founder in the Romandie it is the marquee venue to reach NGOs, multilateral health bodies, and impact funders.
